US5717030A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Adjunctive polymer system for use with medical device
Assignee: Tolmar Therapeutics Inc
•
Filing: 1996-12-06
•
Granted: 1998-02-10
•
Expires: 2016-12-06
Abstract
Abstract A medical device which is a surgically implantable device coated with an adjunctive polymer system. The adjunctive polymer system forms a solid matrix when introduced into a human or animal body. The adjunctive polymer system can contain a drug or a medicament which is released over time from the solid matrix. The adjunctive polymer system contacts body tissue into which the surgically implantable device is implanted.
Inventors
- 👤 Richard L. Dunn
- 👤 Gerald L. Yewey
- 👤 Jeffrey L. Southard
- 👤 John E. Urheim
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 20:03
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61L; A61L15/00; A61L15/16; A61L15/42; A61L15/44; A61L15/62; A61L15/64; A61L17/00; A61L17/06; A61L24/00; A61L24/001; A61L24/0042; A61L26/00; A61L26/0061; A61L26/0066; A61L26/0076; A61L26/009; A61L27/00; A61L27/50; A61L27/54; A61L27/58; A61L29/00; A61L29/14; A61L29/148; A61L29/16; A61L31/00; A61L31/14; A61L31/148; A61L31/16; A61L2300/00; A61L2300/40; A61L2300/43; A61L2300/60; A61L2300/602; A61L2300/606; A61L2300/62; Y; Y10; Y10S; Y10S528/00; Y10S528/905; Y10S602/00; Y10S602/904
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
139 words
A coated wound dressing for sealing a wound in an internal tissue or organ when placed in contact with the wound, comprising: a fibrous wound dressing coated with an adjunctive polymer system to form the coated wound dressing, wherein the adjunctive polymer system comprises a pharmaceutically acceptable, biodegradable thermoplastic polymer that is insoluble in water or body fluids mixed with a biocompatible organic solvent which solubilizes the polymer and is miscible to dispersible in water or body fluids and capable of dissipating or dispersing from the adjunctive polymer system into surrounding tissue fluid whereupon the organic solvent dissipates or disperses into the surrounding tissue and the thermoplastic polymer coagulates to form a solid matrix, the proportion of thermoplastic polymer and solvent, and the polymer molecular weight being selected so as to provide said dissipation or dispersion and said coagulation.
Claim 2
Dependent Claim
139 words
A coated wound dressing for sealing a wound in an internal tissue or organ when placed in contact with the wound, comprising: a fibrous wound dressing coated with an adjunctive polymer system to form the coated wound dressing, wherein the adjunctive polymer system comprises a pharmaceutically acceptable, biodegradable thermoplastic polymer that is insoluble in water or body fluids mixed with a biocompatible organic solvent which solubilizes the polymer and is miscible to dispersible in water or body fluids and capable of dissipating or dispersing from the adjunctive polymer system into surrounding tissue fluid whereupon the organic solvent dissipates or disperses into the surrounding tissue and the thermoplastic polymer coagulates to form a solid matrix, the proportion of thermoplastic polymer and solvent, and the polymer molecular weight being selected so as to provide said dissipation or dispersion and said coagulation.
Claim 3
Dependent Claim
27 words
The wound dressing according to claim 1, wherein the fibrous wound dressing is selected from the group consisting of fabric, mesh, webbing, cloth, net and combinations thereof.
Claim 4
Dependent Claim
19 words
The wound dressing according to claim 1, wherein a biologically active agent is incorporated into the adjunctive polymer system.
Claim 5
Dependent Claim
14 words
The wound dressing according to claim 1, wherein the fibrous wound dressing is biodegradable.
Claim 6
Dependent Claim
33 words
The wound dressing according to claim 3, wherein the biologically active agent is selected from the group consisting of antibiotics, analgesics, growth promoting agents, clotting agents, anesthetics, antiseptics, antioxidants, anti-inflammatories, and mixtures thereof.
Claim 7
Dependent Claim
36 words
The wound dressing according to claim 3, wherein the biologically active agent is contained within a controlled release component selected from the group consisting of a nanoparticle, cyclodextrin, microcapsule, micelle, liposome, fiber, bead, and combinations thereof.
Claim 8
Dependent Claim
36 words
The wound dressing according to claim 3, wherein the biologically active agent is a low water-solubility salt of the active agent, a complex of the active agent, a conjugate of the active agent, and combinations thereof.
Claim 9
Dependent Claim
26 words
The wound dressing according to claim 1, wherein the internal tissue or organ is selected from the group consisting of an artery, vein, liver and pancreas.
References Cited (Backward Citations)
US2155658A
Cited
US3463158A
Cited
US3887699A
Cited
US3773919A
Cited
US3991766A
Cited
US4076798A
Cited
US4122129A
Cited
US4105034A
Cited
US4181983A
Cited
US4272518A
Cited
US4793336A
Cited
US4631188A
Cited
EP0159293A1
Cited
DD281908A7
Cited
US4780320A
Cited
US4981696A
Cited
US4913903A
Cited
US5013553A
Cited
EP0305175A1
Cited
US5278201A
Cited
US4938763B1
Cited
US4938763A
Cited
US5340849A
Cited
WO1990003768A1
Cited
US5278202A
Cited
US5324520A
Cited
US5457141A
Cited
US5368859A
Cited
WO1991001126A1
Cited
US5324519A
Cited
US5077049A
Cited
WO1992000718A1
Cited
US5266359A
Cited
US5154706A
Cited
EP0537559A1
Cited
EP0539751A1
Cited
US5409966A
Cited
EP0560014A1
Cited
US5461124A
Cited
EP0649662A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-02-09 | 2001-08-11 | 2002-02-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-02-09 | 2005-08-11 | 2006-02-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-02-09 | 2009-08-11 | 2010-02-10 | $7700.00 | Window Closed / Lapsed |